Subscribe to RSS

DOI: 10.1055/s-0045-1807244
Rationale for Imaging Referral Guidelines in Rectal Cancer Patients

Abstract
Rectal carcinoma is an important cause of cancer-related morbidity and mortality worldwide, with an increasing incidence among young patients. Rectal cancers differ anatomically from other colonic cancers due to their proximity to critical pelvic structures like the anal sphincters and urinary bladder. Advances in surgical techniques (total mesorectal excision) and the introduction of neoadjuvant chemoradiotherapy have improved survival, reduced recurrence, and significantly reduced postoperative incontinence in these patients.
Imaging is crucial for preoperative staging and prognostication, defining surgical planes, planning and assessing response to neoadjuvant therapy, and long-term surveillance. High-resolution pelvic magnetic resonance is considered the workhorse for evaluating rectal carcinoma malignancies. As a result, the radiologist is a vital part of the multidisciplinary team comprising surgeons, gastroenterologists, medical and radiation oncologists, and pathologists in managing rectal cancer.
This review aims to provide a comprehensive insight into the imaging recommendations for rectal cancer evaluation at different time points of the management algorithm of rectal carcinoma and the rationale behind them.
Publication History
Article published online:
02 April 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
- 2 Bose B, Clarke J, Glasbey JC. et al; CROCODILE study group. Catastrophic expenditure and treatment attrition in patients seeking comprehensive colorectal cancer treatment in India: a prospective multicentre study. Lancet Reg Health Southeast Asia 2022;6
- 3 Stitzenberg KB, Barnes E. Advances in rectal cancer surgery. Clin Colorectal Cancer 2022; 21 (01) 55-62
- 4 Cerdan-Santacruz C, São Julião GP, Vailati BB, Corbi L, Habr-Gama A, Perez RO. Watch and wait approach for rectal cancer. J Clin Med 2023; 12 (08) 2873
- 5 Glynne-Jones R, Wyrwicz L, Tiret E. et al; ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28 (Suppl. 04) iv22-iv40
- 6 Abbas AM, Sheha AM, Salem MN, Altraigey A. Three-dimensional power Doppler ultrasonography in evaluation of adnexal masses. Middle East Fertil Soc J 2017; 22 (04) 241-245
- 7 Engel R, Kudura K, Antwi K. et al. Diagnostic accuracy and treatment benefit of PET/CT in staging of colorectal cancer compared to conventional imaging. Surg Oncol 2024; 57: 102151
- 8 Cerny M, Dunet V, Prior JO. et al. Initial staging of locally advanced rectal cancer and regional lymph nodes: comparison of diffusion-weighted MRI with 18F-FDG-PET/CT. Clin Nucl Med 2016; 41 (04) 289-295
- 9 Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol 2007; 17 (02) 379-389
- 10 Ippolito D, Drago SG, Franzesi CT, Fior D, Sironi S. Rectal cancer staging: multidetector-row computed tomography diagnostic accuracy in assessment of mesorectal fascia invasion. World J Gastroenterol 2016; 22 (20) 4891-4900
- 11 Maino C, Vernuccio F, Cannella R. et al. Liver metastases: the role of magnetic resonance imaging. World J Gastroenterol 2023; 29 (36) 5180-5197
- 12 Chan BPH, Patel R, Mbuagbaw L, Thabane L, Yaghoobi M. EUS versus magnetic resonance imaging in staging rectal adenocarcinoma: a diagnostic test accuracy meta-analysis. Gastrointest Endosc 2019; 90 (02) 196-203.e1
- 13 Sinha R, Verma R, Rajesh A, Richards CJ. Diagnostic value of multidetector row CT in rectal cancer staging: comparison of multiplanar and axial images with histopathology. Clin Radiol 2006; 61 (11) 924-931
- 14 Tsili AC, Alexiou G, Naka C, Argyropoulou MI. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis. Acta Radiol 2021; 62 (03) 302-312
- 15 Benson AB, Venook AP, Al-Hawary MM. et al. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2022; 20 (10) 1139-1167
- 16 Caruso D, Polici M, Bellini D, Laghi A. ESR essentials: imaging in colorectal cancer-practice recommendations by ESGAR. Eur Radiol 2024; 34 (09) 5903-5910
- 17 Al-Sukhni E, Milot L, Fruitman M. et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol 2012; 19 (07) 2212-2223
- 18 MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333 (7572) 779
- 19 Xie H, Zhou X, Zhuo Z, Che S, Xie L, Fu W. Effectiveness of MRI for the assessment of mesorectal fascia involvement in patients with rectal cancer: a systematic review and meta-analysis. Dig Surg 2014; 31 (02) 123-134
- 20 Chandramohan A, Mittal R, Dsouza R. et al. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis 2022; 24 (04) 428-438
- 21 Bogveradze N, Lambregts DMJ, El Khababi N. et al; MRI rectal study group. The sigmoid take-off as a landmark to distinguish rectal from sigmoid tumours on MRI: reproducibility, pitfalls and potential impact on treatment stratification. Eur J Surg Oncol 2022; 48 (01) 237-244
- 22 Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol 2019; 92 (1096) 20180655
- 23 Jhaveri KS, Hosseini-Nik H, Thipphavong S. et al. MRI detection of extramural venous invasion in rectal cancer: correlation with histopathology using elastin stain. AJR Am J Roentgenol 2016; 206 (04) 747-755
- 24 Attenberger UI, Pilz LR, Morelli JN. et al. Multi-parametric MRI of rectal cancer - do quantitative functional MR measurements correlate with radiologic and pathologic tumor stages?. Eur J Radiol 2014; 83 (07) 1036-1043
- 25 Detering R, van Oostendorp SE, Meyer VM. et al; Dutch ColoRectal Audit Group*. MRI cT1-2 rectal cancer staging accuracy: a population-based study. Br J Surg 2020; 107 (10) 1372-1382
- 26 Reginelli A, Clemente A, Sangiovanni A. et al. Endorectal ultrasound and magnetic resonance imaging for rectal cancer staging: a modern multimodality approach. J Clin Med 2021; 10 (04) 641
- 27 Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep 2016; 6 (01) 29765
- 28 Cohen R, Platell CF. Metachronous colorectal cancer metastasis: who, what, when and what to do about it. J Surg Oncol 2024; 129 (01) 71-77
- 29 O'Leary MP, Parrish AB, Tom CM, MacLaughlin BW, Petrie BA. Staging Rectal cancer: the utility of chest radiograph and chest computed tomography. Am Surg 2016; 82 (10) 1005-1008
- 30 Shenoy-Bhangle A, Baliyan V, Kordbacheh H, Guimaraes AR, Kambadakone A. Diffusion weighted magnetic resonance imaging of liver: principles, clinical applications and recent updates. World J Hepatol 2017; 9 (26) 1081-1091
- 31 Chen MZ, Zhang X, Mui M, Kong JCH, Heriot AG, Ellis-Clark J. Retrospective audit: utility of PET scan in routine preoperative rectal cancer staging. ANZ J Surg 2023; 93 (03) 617-621
- 32 Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23 (24) 5644-5650
- 33 Secerov Ermenc A, Segedin B. The role of MRI and PET/CT in radiotherapy target volume determination in gastrointestinal cancers-review of the literature. Cancers (Basel) 2023; 15 (11) 2967
- 34 De Pietro S, Di Martino G, Caroprese M. et al. The role of MRI in radiotherapy planning: a narrative review “from head to toe”. Insights Imaging 2024; 15 (01) 255
- 35 Ryan JE, Warrier SK, Lynch AC, Ramsay RG, Phillips WA, Heriot AG. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Colorectal Dis 2016; 18 (03) 234-246
- 36 Patel UB, Blomqvist LK, Taylor F. et al. MRI after treatment of locally advanced rectal cancer: how to report tumor response–the MERCURY experience. AJR Am J Roentgenol 2012; 199 (04) W486-95
- 37 Bates DDB, Golia Pernicka JS, Fuqua III JL. et al. Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study. Abdom Radiol (NY) 2020; 45 (02) 293-300
- 38 Nougaret S, Rousset P, Lambregts DMJ. et al. MRI restaging of rectal cancer: the RAC (Response-Anal canal-CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups. Diagn Interv Imaging 2023; 104 (7-8): 311-322
- 39 Lu QY, Guan Z, Zhang XY. et al. Contrast-enhanced MRI for T restaging of locally advanced rectal cancer following neoadjuvant chemotherapy and radiation therapy. Radiology 2022; 305 (02) 364-372
- 40 Battersby NJ, Dattani M, Rao S. et al. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial. Trials 2017; 18 (01) 394
- 41 Korngold EK, Moreno C, Kim DH. et al; Expert Panel on Gastrointestinal Imaging. ACR Appropriateness Criteria® staging of colorectal cancer: 2021 update. J Am Coll Radiol 2022; 19 (5S): S208-S222
- 42 Murcia Duréndez MJ, Frutos Esteban L, Luján J. et al. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Nucl Med Mol Imaging 2013; 40 (01) 91-97
- 43 Yuval JB, Patil S, Gangai N. et al. MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study. Eur Radiol 2023; 33 (08) 5761-5768
- 44 Park S, Park HS, Jang S. et al. Utility of abbreviated MRI in the post-treatment evaluation of rectal cancer. Acta Radiol 2024; 65 (07) 689-699
- 45 Nors J, Iversen LH, Erichsen R, Gotschalck KA, Andersen CL. Incidence of recurrence and time to recurrence in stage I to III colorectal cancer: a nationwide Danish cohort study. JAMA Oncol 2024; 10 (01) 54-62
- 46 Swartjes H, van Rees JM, van Erning FN. et al. Locally recurrent rectal cancer: toward a second chance at cure? A population-based, retrospective cohort study. Ann Surg Oncol 2023; 30 (07) 3915-3924
- 47 Jayaprakasam VS, Alvarez J, Omer DM, Gollub MJ, Smith JJ, Petkovska I. Watch-and-wait approach to rectal cancer: the role of imaging. Radiology 2023; 307 (01) e221529
- 48 Byun HK, Koom WS. A practical review of watch-and-wait approach in rectal cancer. Radiat Oncol J 2023; 41 (01) 4-11